Abstract
“Reverse” cholesterol transport (RCT) from peripheral tissues to the liver is believed to play a major role in preventing accumulation of this lipid locally. Lipid-poor (prebeta-migrating) high-density lipoprotein (prebeta-HDL) plays a key and probably rate-limiting role in RCT, even though only a small proportion of the cholesterol content of circulating HDL originates from RCT. Normal RCT is explained here on the basis of a two-compartment recycling model. Prebeta-HDL is lipidated in interstitial fluid and lymph by ATP-dependent lipid transporters. These particles are then passed to the plasma compartment, where they become lipid-filled under the influence of the lecithin:cholesterol acyltransferase (LCAT) reaction without further input from transporters. In atherosclerosis, where activated macrophages are uniquely in contact with plasma, lipid transporters can directly stimulate RCT driven by LCAT.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adorni MP, Zimetti F, Billheimer JT, Wang N, Rader DJ, Phillips MC, Rothblat GH (2007) The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res 48:2453–2462
Cao G, Garcia CK, Wyne KL, Scultz RA, Parker KL, Hobbs HH (1997) Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor-1. J Biol Chem 272:33068–33076
Capponi AM (2002) Regulation of cholesterol supply for mineralocorticoid biosynthesis. Trends Encrocrin Metab 13:118–121
Cavelier C, Lorenzi I, Rohrer L, von Eckardstein A (2006) Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim Biophys Acta 1761:655–666
Chau P, Nakamura Y, Fielding CJ, Fielding PE (2006) Mechanism of prebeta HDL formation and activation. Biochemistry 45:3981–3987
Chau P, Fielding PE, Fielding CJ (2007) Bone morphogenetic protein-1 (BMP-1) cleaves human proapolipoprotein A1 and regulates its activation for lipid binding. Biochemistry 46:8445–8450
Clark SB, Norum KR (1977) The lecithin-cholesterol acyltrasnferase activity of lymph. J Lipid Res 18:293–300
Curtiss LK, Bonnet DJ, Rye KA (2000) The conformation of apolipoprotein A-I in high density lipoproteins is influenced by lipid composition and particle size: a surface plasmon resonance study. Biochemistry 39:5712–5721
Dietschy JM, Turley SD (2002) Control of cholesterol turnover in the mouse. J Biol Chem 277:3801–3804
Fielding CJ, Fielding PE (2001) Cellular cholesterol efflux. Biochim Biophys Acta 1533:175–189
Fielding CJ, Fielding PE (2007) Reverse cholesterol transport - new roles for prebeta1-HDL and lecithin:cholesterol acyltransferase. In: Fielding CJ (ed) High density lipoproteins. Wiley-VCH, Weinheim, pp 143–161
Fielding CJ, Fielding PE (2008) In: Vance D, Vance J(eds) Lipids, lipoproteins and membranes, 5th edn. Elsevier, London, pp 533–553
Fielding PE, Fielding CJ (1995) Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34:14288–14292
Fielding CJ, Bist A, Fielding PE (1999) Intracellular cholesterol transport in synchronized human skin fibroblasts. Biochemistry 38:2506–2513
Fielding PE, Nagao K, Hakamata H, Chimini G, Fielding CJ (2000) A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-I. Biochemistry 39:14113–14120
Hassan HH, Denis M, Krimbou L, Marcil M, Genest J (2006) Cellular cholesterol homeostasis in vascular endothjelial cells. Can J Cardiol 22:35B–40B
Hennessy LK, Kunitake ST, Kane JP (1993) Apolipoprotein-AI-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of prebeta high density lipoprotein particles. Biochemistry 32:5759–5765
Hill WG, Almasri E, Ruiz WG, Apodaca G, Zeidel ML (2005) Water and solute permeability of rat lung caveolae: high permeabilities explained by acyl chain unsaturation. Am J Physiol Cell Physiol 289:C33–C41
Kawano M, Miida T, Fielding CJ, Fielding PE (1993) Quantitation of prebeta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipids. Biochemistry 32:5025–5028
Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, Fishbein MC, Frank J Francone OL, Edwards PA (2005) ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 1:121–131
Krimbou L, Marcil M, Genest J (2006) New insights into the biogenesis of human high-density lipoproteins. Curr Opin Lipidol 17:258–267
Kujiraoka T, Nanjee MN, Oka T, Ito M, Nagano M, Cooke CJ, Takahashi S, Olszewski WL, Wong JS, Stepanova IP, Hamilton RL, Egashira T, Hattori H, Miller NE (2003) Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP and CETP in plasma and peripheral lymph in humans. Arterioscler Thromb Vasc Biol 23:1653–1659
Lee JY, Lanningham-Foster L, Boudyguina EY, Smith TL, Young ER, Colvin PL, Thomas MJ, Parks JS (2004) Prebeta high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice. J Lipid Res 45:716–728
Lee-Rueckert M, Vikstedt R, Metso J, Ehnholm C, Kovanen PT, Jauhiainen M (2006) Absence of endogeneous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells. J Lipid Res 47:1725–1732
Lewis GF, Rader DJ (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96:1221–1232
Lin YC, Ma C, Hsu WC, Lo HF, Yang VC (2007) Molecular interaction between caveolin-1 and ABCA1 on high density lipoprotein-mediated cholesterol efflux in aortic endothelial cells. Cardiovascular Res 75:575–583
Mendez AJ, Lin G, Wade DP, Lawn RM, Oram JF (2001) Membrane domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem 276:3158–3166
Mitchell CD, King WC, Applegate KR, Forte T, Glomset JA, Norum KR, Gjone E (1980) Characterization of apolipoprotein E-rich high density lipoproteins in familial lecithin:cholesterol acyltransferase deficiency. J Lipid Res 21:625–634
Nakamura Y, Kotite L, Gan Y, Spencer TA, Fielding CJ, Fielding PE (2004) Molecular mechanism of reverse cholesterol transport: reaction of prebeta-migrating high density lipoprotein with plasma lecithin:cholesterol acyltransferase. Biochemistry 43:14811–14820
Nanjee MN, Cooke CJ, Olszewski WL, Miller NE (2000) Concentrations of electrophoretic and size subclasses of apolipoprotein AI-containing particles in human peripheral lymph. Arterioscler Thromb Vasc Biol 20:2148–2155
Nikkari T, Schreibman PH, Ahrens EH (1975) Isotope kinetics of human skin cholesterol secretion. J Exp Med 141:620–634
O’Connell BJ, Denis M, Genest J (2004) Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation 110:2881–2888
Oram JF, Wolfbauer G, Vaughan AM, Tang C, Albers JJ (2003) Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J Biol Chem 278:52379–52385
Ortegren U, Karlsson M, Blazic N, Blomqvist M, Nystrom FH, Gustavsson J, Fredman P, Stralfors P (2004) Lipids and glycosphingolipids in caveolae and surrounding plasma membrane of primary rat adipocytes. Eur J Biochem 271:2028–2036
Out R, Hoekstra M, Habets K, Meurs I, de Waard V, Hildebrand RB, Wang Y, Chimini G, Kuiper J, Van Berkel TJ, Van Eck M (2008) Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler Thromb Vasc Biol 28:258–264
Parpal S, Karlsson M, Thorn H, Stralfors P (2001) Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1 but not for mitogen-activated protein kinase control. J Biol Chem 276:9670–9678
Rothblat GH, Mahlberg FH, Johnson WJ, Phillips MC (1992) Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J Lipid Res 33:1091–1097
Sdrobnik W, Borsukova H, Bottcher A, Pfeiffer A, Liebisch G, Schutz GJ, Schindler H, Schmitz G (2002) Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 3:268–278
Sens P, Turner MS (2004) Theoretical model for the formation of caveolae and similar membrane invaginations. Biophys J 86:2049–2057
Singaraja RR, Visscher H, James ER, Chroni A, Coutinho JM, Brunham LR, Kang MH, Zannis VI, Chimini G, Hayden MR (2006) Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro. Circ Res 99:389–397
Sparks DL, Frank PG, Braschi S, Neville TA, Marcel YL (1999) Effect of apolipoprotein A-I lipidation on the formation and function of prebeta- and alpha-migrating LpA-I particles. Biochemistry 38:1727–1735
Wang N, Silver DL, Costet P, Tall AR (2000) Specific binding of apo A-I, enhanced cholesterol efflux and altered plasma membrane morphology in cells expressing ABCA1. J Biol Chem 275:33053–33058
Wolfrum C, Poy MN, Stoffel M (2005) Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11:418–422
Zeidan A, Broman J, Hellstrand P, Sward K (2003) Cholesterol dependence of vascular ERK1/2 activation and growth in response to stretch: role of endothelin-1. Arterioscler Thromb Vasc Biol 23:1528–1534
Zha X, Gauthier A, Genest J, McPherson R (2003) Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux. J Biol Chem 278:10002–10005
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fielding, C.J. (2009). Cellular Cholesterol Transport–Microdomains, Molecular Acceptors and Mechanisms. In: Ehnholm, C. (eds) Cellular Lipid Metabolism. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00300-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-00300-4_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00299-1
Online ISBN: 978-3-642-00300-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)